Markets are Closed
Company Logo
AZN
Astrazeneca PLC

Open

0

Previous Open

52.87

High

0

Previous High

53.36

Low

0

Previous Low

52.54

Close

0

Previous Close

53.07

Volume

0

Previous Volume

5,760,981

Company Profile

Description

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Exchange

New York Stock Exchange

List Date

April 06, 1999

CEO

Pascal Soriot

Employees

61,100

Financials

Revenue

24.38B

Earnings

2.98B
24B
19B
13B
8B
3B
2017
2017
2018
2018

Splits

July 24, 20150.50%
April 08, 19980.33%

Dividends

March 30, 2020$0.93
September 09, 2019$0.44
March 27, 2019$0.93
September 10, 2018$0.44
March 19, 2018$0.93
September 11, 2017$0.44
March 20, 2017$0.93
September 12, 2016$0.44
March 21, 2016$0.93
September 14, 2015$0.44
March 23, 2015$0.94
September 15, 2014$0.90
March 24, 2014$1.90
September 16, 2013$0.90

Related News

News post image: How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - March 24, 2020
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - March 24, 2020
Mar 24, 2020 @ 14:51
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields....
finance yahoo
News post image: First Patient Dosed in IPH5201 Phase I Clinical Trial in Advanced Solid Tumors
First Patient Dosed in IPH5201 Phase I Clinical Trial in Advanced Solid Tumors
Mar 10, 2020 @ 06:00
Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the first patient was dosed in a Phase I clinical trial evaluating IPH5201, an anti-CD39 blocking monoclonal antibody, in adult patients with advanced solid tumors. The purpose...
finance yahoo
News post image: Pharma Stock Roundup: FDA Updates From LLY, GSK, NVS, SNY to Spin-Off API Unit
Pharma Stock Roundup: FDA Updates From LLY, GSK, NVS, SNY to Spin-Off API Unit
Feb 28, 2020 @ 14:55
FDA accepts Glaxo (GSK) and Novartis' (NVS) sBLA. FDA gives approval to Lilly's (LLY) Trulicity for cardiovascular indication....
finance yahoo
News post image: NeoTX Closes $45 Million Series C Financing
NeoTX Closes $45 Million Series C Financing
Feb 19, 2020 @ 08:00
REHOVOT, Israel, Feb. 19, 2020 -- NeoTX Therapeutics, a clinical-stage biotechnology company leveraging its proprietary Selective T cell Redirection (STR) platform to develop....
finance yahoo
News post image: Merck (MRK) Beats on Q4 Earnings, Plans Women Health Spin Off
Merck (MRK) Beats on Q4 Earnings, Plans Women Health Spin Off
Feb 05, 2020 @ 14:47
Merck (MRK) beats estimates for earnings but misses the same for sales in fourth-quarter 2019. The company plans to spin off Women Health drugs/biosimilars into new company. Shares down....
finance yahoo
News post image: JPMorgan to buy Paris building to bring euro teams from London
JPMorgan to buy Paris building to bring euro teams from London
Jan 19, 2020 @ 20:15
U.S. bank JPMorgan Chase & Co said it plans to buy a building in central Paris to house up to 450 staff in coming years, as it relocates some services from London after Britain's exit from the European Union. The expansion is expected to make the French capital where it currently has 260 staff,...
finance yahoo
News post image: Pfizer/Merck KGaA's Bavencio Positive in Bladder Cancer Study
Pfizer/Merck KGaA's Bavencio Positive in Bladder Cancer Study
Jan 07, 2020 @ 14:42
Pfizer (PFE) and Merck KGaA's Bavencio meets the primary goal in a late-stage study evaluating it as a first-line maintenance therapy for metastatic urothelial carcinoma, a form of bladder cancer....
finance yahoo
News post image: Roche's Tecentriq-Chemo Combo Gets FDA Nod in First-Line NSCLC
Roche's Tecentriq-Chemo Combo Gets FDA Nod in First-Line NSCLC
Dec 04, 2019 @ 14:22
Roche (RHHBY) obtains FDA approval for Tecentriq in combination with chemotherapy for the first-line treatment of adults with metastatic NSCLC....
finance yahoo
News post image: Here's Why Merck's (MRK) Shares Are Up This Year
Here's Why Merck's (MRK) Shares Are Up This Year
Nov 28, 2019 @ 13:44
Merck's (MRK) shares are up 11.7% this year so far on strong performance and positive regulatory updates on its PD-1 inhibitor Keytruda....
finance yahoo
News post image: Spectrum Pharma's (SPPI) Loss Narrows in Q2, Stock Rises
Spectrum Pharma's (SPPI) Loss Narrows in Q2, Stock Rises
Aug 12, 2019 @ 14:47
Spectrum Pharma (SPPI) beats bottom-line estimates in the second quarter....
finance yahoo